HUTCHMED (China) (HCM) Current Assets (2015 - 2025)
HUTCHMED (China)'s (HCM) quarterly Current Assets came in at $1.6 billion in Q4 2025, up 1526.89% year-on-year from $96.3 million in Q4 2024, and down 1.57% on a QoQ basis from $1.6 billion in Q2 2025.
HUTCHMED (China) (HCM) Current Assets (2015 - 2025) Analysis & Trends
HUTCHMED (China) (HCM) has 11 years of Current Assets data on file, last reported at $1.6 billion in Q4 2025.
- On a quarterly basis, Current Assets rose 1526.89% year-over-year to $1.6 billion in Q4 2025; TTM through Dec 2025 was $1.6 billion, a N/A change from a year earlier, with the FY2025 full-year figure at $1.6 billion, up 1537.06% from the prior year.
- Current Assets for Q4 2025 stood at $1.6 billion, down from $1.6 billion in the prior quarter.
- Over the last five years, Current Assets for HCM reached as high as $1.6 billion in Q2 2025 and fell as low as -$73.8 million in Q4 2023.
- Historically, Current Assets has averaged $907.5 million across 5 years, with a median of $1.0 billion in 2024.
- Across the five-year window, Current Assets sank 108.78% in 2023 and jumped 1526.89% in 2025, its largest moves.
- Year by year, Current Assets stood at $1.2 billion in 2021, then plunged by 30.71% to $839.9 million in 2022, then slumped by 108.78% to -$73.8 million in 2023, then soared by 230.59% to $96.3 million in 2024, then soared by 1526.89% to $1.6 billion in 2025.
- Per Business Quant data, the three most recent Current Assets figures were $1.6 billion in Q4 2025, $1.6 billion in Q2 2025, and $96.3 million in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 6.05 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 13.71 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 6.47 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 19.71 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 2.87 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 53.60 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 10.92 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 2.44 Bn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 3.58 Bn |
| 10 | HUTCHMED (China) | 241.90 Mn | 243.61 Mn | - | 1.57 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.57 Bn |
| Jun 30, 2025 | 1.59 Bn |
| Dec 31, 2024 | 96.34 Mn |
| Jun 30, 2024 | 1.05 Bn |
| Dec 31, 2023 | -73.78 Mn |
| Jun 30, 2023 | 1.09 Bn |
| Dec 31, 2022 | 839.89 Mn |
| Jun 30, 2022 | 1.02 Bn |
| Dec 31, 2021 | 1.21 Bn |
| Jun 30, 2021 | 1.09 Bn |
| Mar 31, 2021 | 496.23 Mn |
| Dec 31, 2020 | 530.74 Mn |
| Jun 30, 2020 | 374.73 Mn |
| Dec 31, 2019 | 317.02 Mn |
| Sep 30, 2019 | 277.08 Mn |
| Jun 30, 2019 | 309.50 Mn |
| Mar 31, 2019 | 349.99 Mn |
| Dec 31, 2018 | 370.54 Mn |
| Jun 30, 2018 | 394.68 Mn |
| Dec 31, 2017 | 432.20 Mn |